Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

January 31, 2017- Interviewed by Steven E. Greer, MD Continue reading

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | 1 Comment

The Weekly Summary

May 22nd – May 28th                                 2017

In general news, 22 children and parents were slaughtered in Manchester, England when an ISIS suicide Continue reading

Posted in - The Weekly Summary | Leave a comment

KIT inhibition by Gleevec (imatinib) for severe asthma

May 26, 2017- Interviewed by Steven E. Greer, MD

Novartis’ Gleevec (imatinib) was approved in the U.S. in 2001 to treat leukemia. Now, researchers Continue reading

Posted in - Biotech, - NEJM, - Pharma, National Jewish Health, Pulmonology | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD

We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab Continue reading

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

Review of combination immunotherapies seen at ASCO 2016

June 22, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Weekly Summary

May 15th – May 21st                                 2017

In general news, moderate candidate Rouhini was re-elected in Iran despite anger brewing Continue reading

Posted in - The Weekly Summary | Leave a comment

The Weekly Summary

May 8th – May 14th                                 2017

In general news, North Korea launched another provocative test missile. A global computer virus Continue reading

Posted in - The Weekly Summary | Leave a comment

BRAF and MEK combos for melanoma

Update October 1, 2015- The FDA approved the use of two drugs, Opdivo and Yervoy, to treat metastatic melanoma, as we first discussed with Dr. Ribas last year.  Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Weekly Summary

May 1st – May 7th                                 2017

 In general news, France elected moderate Macaron instead of FREXIT proponent Le Pen. In the Continue reading

Posted in - The Weekly Summary | Leave a comment

Trump made a big mistake wading into the quagmire of healthcare

Is President Obama foreseeing the future here and having a laugh?

May 7, 2017- Opinion by Steven E. Greer, MD

I watched Face the Nation and the news coverage of Friday town hall meetings. Mick Mulvaney was Continue reading

Posted in - Opinion, CMS, Congress | Leave a comment

Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.

October 23, 2013- Interviewed by Steven E. Greer, MD

The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer. Continue reading

Posted in - Medical Devices, Diabetes and endocrinology, FDA | Leave a comment

Antoni Ribas, MD discusses cancer drugs targeting the PD1 signaling pathways

March 19, 2013- Interviewed by Steven E. Greer, MD

The upcoming ASCO meeting will be dominated by numerous presentations relating to new Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD

Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the Continue reading

Posted in - Policy, FDA | 1 Comment

Are the new PCSK9 cholesterol lowering drugs worth the high cost?

December 16, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA | Leave a comment

The Weekly Summary

April 24th – April 30th                                 2017

In general news, President Trump warned North Korea again after they test fired a missile. Continue reading

Posted in - The Weekly Summary | Leave a comment

An emerging safety problem for TAVR patients

March 16, 2017- produced and interviewed by Steven E. Greer, MD

We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement (TAVR) valve. The products have been approved by the FDA for several years, and we asked him to update us on the real-world usage and safety. Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

Why Indian Point nuclear power plant needs to be shut down

April 29, 2017- by Steven E. Greer, MD

I have long been a critic of the overuse of CT-scans due to the dangers of radiation. I’m not sure why, Continue reading

Posted in - Opinion, - Policy, CDC, Congress, Emergency medicine, Obstetrics and Gynecology, Radiology, UC San Francisco | Leave a comment

The Weekly Summary

April 17th – April 23rd                                 2017

In general news, Paris suffered yet another radical Islamic attack when a man shot and killed a police officer. Continue reading

Posted in - The Weekly Summary | Leave a comment

The Weekly Summary

April 10th – April 16th                                 2017

In general news, the Trump administration accused Russia of being complicit with the Syrian Continue reading

Posted in - The Weekly Summary | Leave a comment

The Weekly Summary

April 3rd – April 9th                                 2017

In general news, Syria and Russia’s military teamed up to unleashed nerve gas attacks on rebels, which provoked President Trump into launching 59 cruise missiles to bomb the airbase. Continue reading

Posted in - The Weekly Summary | Leave a comment